Adding an Internet-delivered treatment to an efficacious treatment package for opioid dependence
- PMID: 25090043
- PMCID: PMC4244262
- DOI: 10.1037/a0037496
Adding an Internet-delivered treatment to an efficacious treatment package for opioid dependence
Abstract
Objective: To examine the benefit of adding an Internet-delivered behavior therapy to a buprenorphine medication program and voucher-based motivational incentives.
Method: A block-randomized, unblinded, parallel, 12-week treatment trial was conducted with 170 opioid-dependent adult patients (mean age = 34.3 years; 54.1% male; 95.3% White). Participants received an Internet-based community reinforcement approach intervention plus contingency management (CRA+) and buprenorphine or contingency management alone (CM-alone) plus buprenorphine. The primary outcomes, measured over the course of treatment, were longest continuous abstinence, total abstinence, and days retained in treatment.
Results: Compared to those receiving CM-alone, CRA+ recipients exhibited, on average, 9.7 total days more of abstinence (95% confidence interval [CI = 2.3, 17.2]) and had a reduced hazard of dropping out of treatment (hazard ratio = 0.47; 95% CI [0.26, 0.85]). Prior treatment for opioid dependence significantly moderated the additional improvement of CRA+ for longest continuous days of abstinence.
Conclusions: These results provide further evidence that an Internet-based CRA+ treatment is efficacious and adds clinical benefits to a contingency management/medication based program for opioid dependence.
Trial registration: ClinicalTrials.gov NCT00929253.
Figures
References
-
- Aickin M. A program for balancing the allocation of subjects to treatment in a clinical trial. Computers and Biomedical Research. 1982;15(6):519–524. - PubMed
-
- Anker AL, Crowley TJ. Use of contingency contracts in speciality clinics for cocaine abuse. In: Harris LS, editor. Problems of Drug Dependence 1981 (NIDA Research Monograph No.41) Rockville, MD: Department of Health and Human Services, National Institute on Drug Abuse; 1982. pp. 452–459. - PubMed
-
- Bickel WK, Amass L, Crean JP, Badger GJ. Buprenorphine dosing every 1,2, or 3 days in opioid-dependent patients. Psychopharmacology. 1999;146:111–118. - PubMed
-
- Bickel WK, Amass LA. Buprenorphine treatment of opioid dependence: A review. Experimental and Clinical Psychopharmacology. 1995;3:477–489.
Publication types
MeSH terms
Substances
Associated data
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical